GenMark Diagnostics Stock News

CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminar

These winners are positioned for gains even after COVID.

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testi

CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testi

GenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q3 2020 Results - Earnings Call Transcript

CARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial

TRACON Pharmaceuticals gets FDA clearance for ENVASARC pivotal trial. GenMark Diagnostics reports submission of emergency use authorization.

Leveraging GenMark’s eSensor XT-8® platform to expand COVID-19 diagnostic testing capacityCARLSBAD, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading pro

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday

Current market moves may trap the long-term investor. The Great Reset Matrix is a helpful tool for keeping eyes on the future.

GenMark Diagnostics, Inc (NASDAQ:GNMK)’s share price reached a new 52-week high on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $20.79

GenMark Diagnostics (NASDAQ:GNMK) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of th

Most medical diagnostic and research companies tend not to be involved in the COVID-19 virus vaccine race, but entries who are need tools to speed their pace.

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) ABIOMED, Inc. (NASDAQ: ABMD) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...

Before we begin, I would like to inform you that certain statements made by GenMark during the course of this call may constitute forward-looking statements. Any statement about our expectations, bel